A trend for the absence of co-occurrence with GTF2I was observed also for CDKN2A, BAP1, CYLD, and KIT mutations, which are genes frequently mutated in B3 thymomas and thymic carcinomas. Here, BAP1 is linked to thymic carcinoma.